AstraZeneca (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Cambridge

AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England. Its R&D is concentrated in Cambridge, Mölndal in Sweden, and Maryland and Toronto in North America.

Average round investment:220.34M USD
Average number per year:1.5
Distribution: 2025 (2)2024 (3)2023 (1)2022 (1)2020 (1) See the entire list
Mostly invests in: Sweden Sweden (4) Health services (8)
See the entire list

Showing 3 of 9 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to AstraZeneca

Name Criteria
United States Thoma Bravo
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden, Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Thomas H Lee Partners
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, Manufacturing, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States StepStone Group
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Hamilton Lane
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Blackstone
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, AI (big data), Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden, United Kingdom, France, Netherlands
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United States FTV Capital
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Princeville Capital
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Rive private investment
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, AI (big data), Manufacturing, Hardware, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Patient Square Capital
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Software Services, AI (big data), Biotech, Pharma, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States HarbourVest Partners
92%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Software Services, Pharma, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top